在阻塞性呼吸暂停中使用CPAP和视网膜疾病风险:一组研究
Dillan Cunha Amaral1, Pedro Lucas Machado Magalhães2, Muhammad Alfatih3
1Department of Ophthalmology and Otorhinolaryngology, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro 21941-853, RJ, Brazil.
Vision (Basel, Switzerland)
|August 22, 2025
概括
在患有阻塞性睡眠呼吸暂停 (OSA) 的成年人中,持续的正气压 (CPAP) 治疗可能会降低糖尿病视网膜病变和与年龄相关的黄斑退化风险. 需要进一步的研究来证实这些发现.
科学领域:
- 眼科 眼科
- 睡眠医学
- 心血管研究
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 与全身炎症和血管功能障碍有关,导致视网膜疾病.
- 像OSA中间歇性缺氧这样的机制与各种视网膜疾病的发病有关.
研究的目的:
- 评估持续正气道压力 (CPAP) 疗法的有效性,以减少OSA成年人视网膜疾病的发生率.
- 评估CPAP对糖尿病视网膜病变 (DR),与年龄相关的黄斑变性 (AMD),视网膜静脉封闭 (RVO) 和中枢血清性视网膜病变 (CSC) 的影响.
主要方法:
- 使用TriNetX研究网络进行的回顾性队列研究.
- 在1:1倾向性比分匹配后,分析了101,754名OSA成年患者,BMI为25. 030. 0kg/ m2.
- 在接受CPAP治疗和未接受CPAP治疗的患者中,对DR,AMD,RVO和CSC的发生率进行了比较.
主要成果:
- 使用CPAP与糖尿病视网膜病变 (DR) (3.2%对3. 4%) 和与年龄相关的黄斑变性 (AMD) (2.1%对2. 3%) 的发生率有统计学意义的降低有关.
- 视网膜静脉封闭 (RVO) 或中央血清静脉病变 (CSC) 的发生率在两组之间没有显著差异.
- 对DR和AMD的相对风险降低分别为0. 922 (p=0. 016) 和0. 906 (p=0. 018).
结论:
- 在患有OSA的成年人中,CPAP治疗对特定的视网膜并发症,特别是DR和AMD具有潜在的保护作用.
- 这些发现支持现有证据,将CPAP与视网膜微血管健康的改善联系起来.
- 需要进一步的前性研究来证实这些结果,考虑到CPAP的坚持和OSA的严重程度等因素.
相关概念视频
Sleep Apnea
220
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
220
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
Photoreceptors and Visual Pathways
6.5K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.5K


